Compare CTKB & HIFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CTKB | HIFS |
|---|---|---|
| Founded | 1990 | 1834 |
| Country | United States | United States |
| Employees | N/A | 97 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 777.3M | 679.7M |
| IPO Year | 2021 | N/A |
| Metric | CTKB | HIFS |
|---|---|---|
| Price | $6.32 | $284.41 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $6.50 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 18.1K |
| Earning Date | 11-04-2026 | 10-16-2026 |
| Dividend Yield | N/A | ★ 0.87% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $193,015,000.00 | N/A |
| Revenue This Year | $3.83 | N/A |
| Revenue Next Year | $6.48 | N/A |
| P/E Ratio | ★ N/A | $12.63 |
| Revenue Growth | ★ 17.67 | N/A |
| 52 Week Low | $3.31 | $255.68 |
| 52 Week High | $6.34 | $338.00 |
| Indicator | CTKB | HIFS |
|---|---|---|
| Relative Strength Index (RSI) | 60.02 | 40.45 |
| Support Level | $4.10 | $278.27 |
| Resistance Level | $6.27 | $292.89 |
| Average True Range (ATR) | 0.37 | 10.54 |
| MACD | 0.01 | -2.49 |
| Stochastic Oscillator | 86.47 | 11.31 |
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.
Hingham Institution for Savings is a Massachusetts-chartered savings bank headquartered in Hingham, Massachusetts. The bank is principally engaged in the business of commercial and residential real estate mortgage lending, funded by a mix of retail and commercial deposits, wholesale deposits and borrowings. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending products are residential and commercial mortgage loans secured by properties in eastern Massachusetts. The bank also lends to commercial and residential real estate borrowers and services deposits for customers in the greater Washington, D.C. metropolitan area (WMA) and in the San Francisco Bay Area.